Ellevest Inc’s Acorda Therapeutics ACOR Stock Holding History

Ellevest Inc’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5	Closed	-$1K	–	1403
2020 Q1	$1K	Buy	5 +1	+25%	+$197	﹤0.01%	1027
2019 Q4	$1K	Buy	+4	New	+$1.01K	﹤0.01%	919

Other funds holding ACOR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ellevest Inc's ACOR Position: Q2 2020 in Review

Ellevest Inc sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 5 shares — an estimated $1K sold.

Ellevest Inc first reported a position in ACOR in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

Ellevest Inc reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
Ellevest Inc sold 5 Acorda Therapeutics shares in Q2 2020, an estimated $1K.
Ellevest Inc first reported a position in Acorda Therapeutics in Q4 2019 and held it in 2 quarters.
Ellevest Inc's Acorda Therapeutics position peaked at $1K in Q1 2020.
79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.